You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Chapter title |
Cognitive Assessment in Alzheimer’s Disease Clinical Trials
|
---|---|
Chapter number | 24 |
Book title |
Biomarkers for Alzheimer’s Disease Drug Development
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7704-8_24 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7703-1, 978-1-4939-7704-8
|
Authors |
Geraint Price |
Abstract |
Many tests are available for the assessment of cognitive function. This chapter describes the common features and practical requirements of test administration, key considerations in the selection and interpretation of tests, and their application in Alzheimer's disease drug development. |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 9 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 2 | 22% |
Other | 1 | 11% |
Lecturer > Senior Lecturer | 1 | 11% |
Lecturer | 1 | 11% |
Researcher | 1 | 11% |
Other | 0 | 0% |
Unknown | 3 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 3 | 33% |
Nursing and Health Professions | 1 | 11% |
Biochemistry, Genetics and Molecular Biology | 1 | 11% |
Unknown | 4 | 44% |